FFA
SNDX icon

Farther Finance Advisors’s Syndax Pharmaceuticals SNDX Stock Holding History

Farther Finance Advisors’s Portfolio SNDX Stock Details SNDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.31K Sell
426
-152
-26% -$3.16K ﹤0.01% 4466
2026
Q1 		$13.8K Buy
578
+37
+7% +$804 ﹤0.01% 3906
2025
Q4 		$11.4K Buy
541
+504
+1,362% +$8.79K ﹤0.01% 3829
2025
Q3 		$569 Buy
37
+14
+61% +$183 ﹤0.01% 4508
2025
Q2 		$215 Sell
23
-48
-68% -$528 ﹤0.01% 4194
2025
Q1 		$853 Sell
71
-86
-55% -$1.21K ﹤0.01% 3662
2024
Q4 		$2.08K Buy
157
+16
+11% +$274 ﹤0.01% 2985
2024
Q3 		$2.71K Buy
141
+11
+8% +$227 ﹤0.01% 2881
2024
Q2 		$2.8K Buy
130
+70
+117% +$1.47K ﹤0.01% 2651
2024
Q1 		$1.43K Hold
60
– – ﹤0.01% 2636
2023
Q4 		$1.3K Buy
+60
New +$922 ﹤0.01% 2626

Other funds holding SNDX

HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
TE
Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
DT
Diversified Trust Memphis, Tennessee $6.24B AUM 28.78% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
HCA
Harbour Capital Advisors Tysons Corner, Virginia $549M AUM 54.99% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PR
PSP Research Newtown Square, Pennsylvania $188M AUM
PRTG
Post Resch Tallon Group Pittsford, New York $145M AUM 25.19% 1-Year Est. Return

Farther Finance Advisors's SNDX Position: Q2 2026 in Review

Farther Finance Advisors reduced its Syndax Pharmaceuticals (SNDX) stake by 26% in Q2 2026, selling an estimated $3.16K and leaving 426 shares worth $9.31K. The position accounts for ﹤0.01% of the portfolio, ranked #4466.

Farther Finance Advisors first reported a position in SNDX in Q4 2023 and has held it in 11 quarters since. The position peaked at $13.8K in Q1 2026. 23 funds tracked by Wall St. Rank hold SNDX as of Q2 2026.

  • Farther Finance Advisors held 426 shares of Syndax Pharmaceuticals worth $9.31K as of Q2 2026.
  • Farther Finance Advisors sold 152 Syndax Pharmaceuticals shares in Q2 2026, an estimated $3.16K.
  • Syndax Pharmaceuticals made up ﹤0.01% of Farther Finance Advisors's portfolio in Q2 2026, its #4466 holding.
  • Farther Finance Advisors first reported a position in Syndax Pharmaceuticals in Q4 2023 and has held it in 11 quarters since.
  • Farther Finance Advisors's Syndax Pharmaceuticals position peaked at $13.8K in Q1 2026.
  • 23 funds tracked by Wall St. Rank held Syndax Pharmaceuticals as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.